This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Roche reported this week that total revenue for its Molecular Diagnostics segment declined 3 percent in the third quarter, compared with the same period one year ago and matching a decline in the second quarter, but overall revenue for its entire Diagnostics business rose 4 percent year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.